You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

CLINICAL TRIALS PROFILE FOR CAP-PROFEN

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for CAP-PROFEN

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT03199417 ↗	Trial Evaluating multimOdal toPical Cream In CompArison to pLacebo (TOPICAL)	Terminated	McMaster University	Phase 2/Phase 3	2017-05-01	Randomized controlled trial regarding the efficacy of a multimodal topical analgesic, Multiprofen, in comparison to placebo cream treatment on knee pain and function in patients with knee osteoarthritis.
NCT03199417 ↗	Trial Evaluating multimOdal toPical Cream In CompArison to pLacebo (TOPICAL)	Terminated	Oakville Trafalgar Memorial Hospital	Phase 2/Phase 3	2017-05-01	Randomized controlled trial regarding the efficacy of a multimodal topical analgesic, Multiprofen, in comparison to placebo cream treatment on knee pain and function in patients with knee osteoarthritis.
NCT03199417 ↗	Trial Evaluating multimOdal toPical Cream In CompArison to pLacebo (TOPICAL)	Terminated	University of Michigan	Phase 2/Phase 3	2017-05-01	Randomized controlled trial regarding the efficacy of a multimodal topical analgesic, Multiprofen, in comparison to placebo cream treatment on knee pain and function in patients with knee osteoarthritis.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for CAP-PROFEN

Condition Name

Chart
Table

Condition Name for CAP-PROFEN
Intervention	Trials
Knee Osteoarthritis	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for CAP-PROFEN
Intervention	Trials
Osteoarthritis	1
Osteoarthritis, Knee	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for CAP-PROFEN

Trials by Country

Map
Table

Trials by Country for CAP-PROFEN
Location	Trials
Canada	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for CAP-PROFEN

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for CAP-PROFEN
Clinical Trial Phase	Trials
Phase 2/Phase 3	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for CAP-PROFEN
Clinical Trial Phase	Trials
Terminated	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for CAP-PROFEN

Sponsor Name

Chart
Table

Sponsor Name for CAP-PROFEN
Sponsor	Trials
McMaster University	1
Oakville Trafalgar Memorial Hospital	1
University of Michigan	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for CAP-PROFEN
Sponsor	Trials
Other	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.